Skip to content

Clinical trials

Musculoskeletal Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Country / region: France Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20122
20131
20142
20153
20163
20171
20181
20193
20207
20215
20225
20237
202412
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Active, not recruiting8
Unknown status8
Recruiting7
Terminated6
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company7
AbbVie4
Fulcrum Therapeutics3
University Hospital, Grenoble3
Assistance Publique - Hôpitaux de Paris2
BioMarin Pharmaceutical2
Calcilytix Therapeutics, Inc., a BridgeBio company2
Centre Hospitalier Universitaire, Amiens2
GCS Ramsay Santé pour l'Enseignement et la Recherche2
Genzyme, a Sanofi Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases62
Genetic Diseases, Inborn13
Bone Diseases11
Muscular Diseases10
Neuromuscular Diseases10
Dwarfism8
Muscular Dystrophies8
Osteochondrodysplasias8
Arthritis7
Mucopolysaccharidosis IV7

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.